Home › Employers › Proteogenomics Research Institute for Systems Medicine
Proteogenomics Research Institute for Systems Medicine: H-1B salaries and sponsorship
Proteogenomics Research Institute for Systems Medicine filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 2. Median offered salary: $77,724.
Does Proteogenomics Research Institute for Systems Medicine sponsor H-1B visas?
Proteogenomics Research Institute for Systems Medicine filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Oct 5, 2023. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Biochemist | 2 | $92,000 |
| Research Associate Molecular Biologist | 1 | $63,447 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $63,447 |
| FY2024 | 2 | $92,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Biochemist | $92,000 | La Jolla, CA | Oct 5, 2023 | Oct 13, 2023 | Certified |
| Biochemist | $92,000 | La Jolla, CA | Oct 3, 2023 | Oct 4, 2023 | Denied |
| Research Associate Molecular Biologist | $63,447 Level I | La Jolla, CA | Mar 9, 2023 | May 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).